Rituximab in severe, treatment-refractory interstitial lung disease

R. Abdullah, D. Ming, G. Keir, T. Maher, A. Wells, E. Renzoni (London, United Kingdom)

Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Session: Connective tissue disease and interstitial lung disease
Session type: Poster Discussion
Number: 5127
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Abdullah, D. Ming, G. Keir, T. Maher, A. Wells, E. Renzoni (London, United Kingdom). Rituximab in severe, treatment-refractory interstitial lung disease. Eur Respir J 2013; 42: Suppl. 57, 5127

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014

Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012

Interstitial lung disease
Source: ERS Course 2018 - Thoracic imaging
Year: 2018


Interstitial lung disease
Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea
Year: 2015



Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: ERS Course 2015
Year: 2015



Interstitial lung disease
Source: Eur Respir Monogr 2014; 66: 218-231
Year: 2014


Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014